Quidel Corp. (QDEL)
-NasdaqGS 22.62 
0.52(2.35%) May 24, 4:00PM EDT
| Prev Close: | 22.10 |
|---|
| Open: | 22.15 |
|---|
| Bid: | 8.67 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 24.43 |
|---|
| Beta: | 0.52 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 22.04 - 22.89 |
|---|
| 52wk Range: | 14.92 - 24.95 |
|---|
| Volume: | 65,553 |
|---|
| Avg Vol (3m): | 243,153 |
|---|
| Market Cap: | 763.00M |
|---|
| P/E (ttm): | 44.62 |
|---|
| EPS (ttm): | 0.51 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Northern Trust President Sells More Than 60K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Mon, May 20)
- QUIDEL CORP /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Fri, May 17)
- Quidel's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)at Seeking Alpha(Wed, May 15)
- Quidel to Present at Bank of America Merrill Lynch 2013 Health Care ConferenceMarketwired(Wed, May 8)
- QUIDEL CORP /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Tue, May 7)
- Quidel Completes Acquisition of BioHelix CorporationMarketwired(Mon, May 6)
- QUIDEL CORP /DE/ FinancialsEDGAR Online Financials(Tue, Apr 30)
- QUIDEL CORP /DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, Apr 24)
- Quidel Corporation's CEO Discusses Q12013 - Earnings Call Transcriptat Seeking Alpha(Tue, Apr 23)
- Quidel Earnings: Here’s Why Shares are Up Nowat Wall St. Cheat Sheet(Tue, Apr 23)
- Quidel Reports First Quarter 2013 Financial ResultsMarketwired(Tue, Apr 23)
- QUIDEL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, FinanciEDGAR Online(Tue, Apr 23)
- Q1 2013 Quidel Corporation Earnings Release - After Market CloseCCBN(Tue, Apr 23)
- Quidel to Hold First Quarter 2013 Financial Results Conference Call on April 23, 2013Marketwired(Wed, Apr 10)
- Quidel Receives CE Mark for Its Molecular Diagnostic Test for Herpes Simplex Viruses (HSV 1, HSV 2) and Varicella-Zoster Virus (VZV)Marketwired(Mon, Mar 25)
Key Statistics
| Forward P/E (1 yr): | 43.50 |
|---|
| P/S (ttm): | 4.16 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.37 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.11 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 3.41 |
|---|
Business Summary
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, womens health, and gastrointestinal diseases.
View More